Technical Analysis for GHSI - Guardion Health Sciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.26 | -0.15% | -0.01 |
GHSI closed down 0.15 percent on Wednesday, October 16, 2024, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Spinning Top | Other | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Narrow Range Bar | Range Contraction | -0.15% | |
| Inside Day | Range Contraction | -0.15% | |
| Wide Bands | Range Expansion | -0.15% | |
| Oversold Stochastic | Weakness | -0.15% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Guardion is an ocular health sciences company that develops, formulates and distributes condition-specific medical foods supported by evidence-based protocols, with an initial medical food product that addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”), and a significant component of functional vision performance. Guardion Health Sciences, Inc. has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Organ Systems Health Sciences Medical Device Macular Degeneration Senescence Age Related Macular Degeneration
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Organ Systems Health Sciences Medical Device Macular Degeneration Senescence Age Related Macular Degeneration
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.3404 |
| 52 Week Low | 1.6369 |
| Average Volume | 149,303 |
| 200-Day Moving Average | 3.11 |
| 50-Day Moving Average | 4.21 |
| 20-Day Moving Average | 4.30 |
| 10-Day Moving Average | 3.29 |
| Average True Range | 0.37 |
| RSI (14) | 44.13 |
| ADX | 22.5 |
| +DI | 30.23 |
| -DI | 26.76 |
| Chandelier Exit (Long, 3 ATRs) | 6.24 |
| Chandelier Exit (Short, 3 ATRs) | 4.14 |
| Upper Bollinger Bands | 6.84 |
| Lower Bollinger Band | 1.76 |
| Percent B (%b) | 0.29 |
| BandWidth | 118.03 |
| MACD Line | -0.42 |
| MACD Signal Line | -0.29 |
| MACD Histogram | -0.1317 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.29 | ||||
| Resistance 3 (R3) | 3.29 | 3.28 | 3.29 | ||
| Resistance 2 (R2) | 3.28 | 3.27 | 3.28 | 3.28 | |
| Resistance 1 (R1) | 3.27 | 3.26 | 3.27 | 3.27 | 3.28 |
| Pivot Point | 3.25 | 3.25 | 3.26 | 3.25 | 3.25 |
| Support 1 (S1) | 3.24 | 3.24 | 3.25 | 3.24 | 3.23 |
| Support 2 (S2) | 3.23 | 3.24 | 3.23 | 3.23 | |
| Support 3 (S3) | 3.22 | 3.23 | 3.22 | ||
| Support 4 (S4) | 3.22 |
